GGrantIndex
Sort

40,608 grants matching prostate cancer

Nanotechnology enabled targeting of p53 deficiency in human cancer

$371,490
Xiaoming He · Ohio State University · R01 · FY2016 · CA

Targeting cytoplasmic SET oncoprotein by sphingolipid analog drugs for the induction of necroptosis to treat lung cancer

$371,477
Besim Ogretmen · Medical University Of South Carolina · R01 · FY2025 · CA

The RCMI Program in Health Disparities Research at Meharry Medical College (Supplement)

$371,473
Samuel E. Adunyah · Meharry Medical College · U54 · FY2020 · MD

Multiparametric Photoacoustic Imaging-Based Identification of Aggressive Prostate Cancer

$371,427
Haichong Zhang · Worcester Polytechnic Institute · DP5 · FY2021 · OD

Dose-Response in Radionuclide Therapy

$371,404
George Sgouros · Johns Hopkins University · R01 · FY2012 · CA

HIV induced anti-cancer HERV immunity in prostate, breast and colon cancers

$371,373
Douglas F Nixon · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA

Role of MED1 in the AR-dependent transcription in advanced prostate cancer

$371,338
Irfan Ahmed Asangani · University Of Pennsylvania · R01 · FY2021 · CA

Biomarkers, mechanisms and modulation of oxidative stress associated risk factors in carcinogenesis

$371,284
Yun Rose Li · Beckman Research Institute/City Of Hope · DP5 · FY2024 · OD

Project 3: Molecular basis for epigenome homeostasis by histone chaperone and acetyltransferase complexes

$371,252
Ronen Marmorstein · University Of Pennsylvania · P01 · FY2021 · AG

THE ROLE OF CENTRAL METABOLISM IN PROSTATE CANCER PROGRESSION

$371,251
University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2008 · Department of the Army

Molecular Correlates of Soy in Humans

$371,250
Northwestern University · R21 · FY2003 · CA

Project 2: Targeting DNA replication in BRCA-associated breast cancer

$371,188
Bing Xia · Rutgers Biomedical And Health Sciences · P01 · FY2023 · CA

Regulation of the Class IA PI 3-kinase PIK3CB

$371,156
Jonathan M. Backer · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · GM

Dose-Response in Radionuclide Therapy

$371,131
George Sgouros · Johns Hopkins University · R01 · FY2015 · CA

Aerosol Therapy for Lung Cancer

$371,115
Brian N Hansen · Aerophase, Inc. · R44 · FY2007 · CA

Control of Prostate-Specific Gene Expression

$371,100
Robert J Matusik · Vanderbilt University · R01 · FY2009 · DK

CLINICAL AND EPIDEMIOLOGICAL CENTER--PROSTATE CANCER

$371,001
Johns Hopkins University · U01 · FY2000 · CA

Adipocyte regulation of tumor survival in metastatic prostate cancer: new targets for therapy

$370,965
Izabela Podgorski · Wayne State University · R01 · FY2024 · CA

CLINICAL ULTRASONIC CHARACTERIZATION OF THE PROSTATE

$370,949
Riverside Research Institute · R01 · FY2002 · CA

CITY OF HOPE SOUTHWEST GROUP CLINICAL TRIALS

$370,946
City Of Hope/Beckman Research Institute · U10 · FY2003 · CA

Novel Insights in the regulation of HIF1alpha Stability

$370,927
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2011 · CA

Novel Insights in the regulation of HIF1alpha Stability

$370,927
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2012 · CA

Dose-Response in Radionuclide Therapy

$370,920
George Sgouros · Johns Hopkins University · R01 · FY2013 · CA

Regulation of mammary branching morphogenesis by Slit/Robo1 signaling

$370,908
Lindsay E Hinck · University Of California Santa Cruz · R01 · FY2011 · GM

In Vivo Oncogene-Induced Tumorigenesis and Escape

$370,903
Lewis A Chodosh · University Of Pennsylvania · R01 · FY2019 · CA